Targeting Twist may provide effective approach for treating triple-negative breast ca

[News]

A new study led by University of Kentucky Markey Cancer Center researcher Peter Zhou shows that targeting Twist, a nuclear protein that is an accelerant of the epithelial-mesenchymal transition (EMT) program in human cells, may provide an effective approach for treating triple-negative breast cancer.

More... (http://www.news-medical.net/news/20140212/Targeting-Twist-may-provide-effective-approach-for-treating-triple-negative-breast-cancer.aspx)